Clinical impact of anti-SSA antigenic specificity on disease activity and patient-reported outcomes in primary Sjögren's disease: a real-life cohort study
Anti-SSA antigenic specificity delineates biologically and clinically distinct phenotypes within SjD. These data support serology-informed, multidimensional disease stratification as a foundation for precision-targeted management in SjD.
Authors
- Gaetano La Rocca (ORCID: https://orcid.org/0000-0002-1808-7090)
- Paola Migliorini (ORCID: https://orcid.org/0000-0001-6433-4964)
- Giovanni Fulvio (ORCID: https://orcid.org/0000-0003-0130-4412)
- Silvia Fonzetti
- Chiara Baldini (ORCID: https://orcid.org/0000-0002-4454-1824)
- Marta Mosca
- C. Porciani (ORCID: https://orcid.org/0000-0002-6771-4361)
- Francesco Ferro (ORCID: https://orcid.org/0000-0003-2834-9768)
- B. Dei
Institutions
- University of Pisa (IT)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.55563/clinexprheumatol/t01mio
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.00